Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years.

Olliaro PL, Kuesel AC, Halleux CM, Sullivan M, Reeder JC.

PLoS Negl Trop Dis. 2018 Nov 15;12(11):e0006837. doi: 10.1371/journal.pntd.0006837. eCollection 2018 Nov. No abstract available.

2.

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.

Verver S, Walker M, Kim YE, Fobi G, Tekle AH, Zouré HGM, Wanji S, Boakye DA, Kuesel AC, de Vlas SJ, Boussinesq M, Basáñez MG, Stolk WA.

Clin Infect Dis. 2018 Jun 1;66(suppl_4):S267-S274. doi: 10.1093/cid/cix1137.

3.

Alternative treatment strategies to accelerate the elimination of onchocerciasis.

Boussinesq M, Fobi G, Kuesel AC.

Int Health. 2018 Mar 1;10(suppl_1):i40-i48. doi: 10.1093/inthealth/ihx054.

4.

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.

Opoku NO, Bakajika DK, Kanza EM, Howard H, Mambandu GL, Nyathirombo A, Nigo MM, Kasonia K, Masembe SL, Mumbere M, Kataliko K, Larbelee JP, Kpawor M, Bolay KM, Bolay F, Asare S, Attah SK, Olipoh G, Vaillant M, Halleux CM, Kuesel AC.

Lancet. 2018 Oct 6;392(10154):1207-1216. doi: 10.1016/S0140-6736(17)32844-1. Epub 2018 Jan 18. Erratum in: Lancet. 2018 Oct 6;392(10154):1196.

5.

Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials.

Gomes MF, de la Fuente-Núñez V, Saxena A, Kuesel AC.

Reprod Health. 2017 Dec 14;14(Suppl 3):172. doi: 10.1186/s12978-017-0430-2.

6.

Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.

Doyle SR, Bourguinat C, Nana-Djeunga HC, Kengne-Ouafo JA, Pion SDS, Bopda J, Kamgno J, Wanji S, Che H, Kuesel AC, Walker M, Basáñez MG, Boakye DA, Osei-Atweneboana MY, Boussinesq M, Prichard RK, Grant WN.

PLoS Negl Trop Dis. 2017 Jul 26;11(7):e0005816. doi: 10.1371/journal.pntd.0005816. eCollection 2017 Jul.

7.

Erratum to: Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic.

Alirol E, Kuesel AC, Guraiib MM, de la Fuente-Núñez V, Saxena A, Gomes MF.

BMC Med Ethics. 2017 Jul 12;18(1):45. doi: 10.1186/s12910-017-0204-y. No abstract available.

8.

Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic.

Alirol E, Kuesel AC, Guraiib MM, de la Fuente-Núñez V, Saxena A, Gomes MF.

BMC Med Ethics. 2017 Jun 26;18(1):43. doi: 10.1186/s12910-017-0201-1. Erratum in: BMC Med Ethics. 2017 Jul 12;18(1):45.

9.

Response to the Letter to the Editor by Eberhard et al.

Bottomley C, Isham V, Vivas-Martínez S, Kuesel AC, Attah SK, Opoku NO, Lustigman S, Walker M, Basáñez MG.

Parasit Vectors. 2017 May 16;10(1):240. doi: 10.1186/s13071-017-2125-5.

10.

Research for new drugs for elimination of onchocerciasis in Africa.

Kuesel AC.

Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):272-286. doi: 10.1016/j.ijpddr.2016.04.002. Epub 2016 May 19. Review.

11.

Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.

Bottomley C, Isham V, Vivas-Martínez S, Kuesel AC, Attah SK, Opoku NO, Lustigman S, Walker M, Basáñez MG.

Parasit Vectors. 2016 Jun 14;9(1):343. doi: 10.1186/s13071-016-1605-3.

12.

Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial.

Kamgno J, Nguipdop-Djomo P, Gounoue R, Téjiokem M, Kuesel AC.

PLoS Negl Trop Dis. 2016 Mar 11;10(3):e0004492. doi: 10.1371/journal.pntd.0004492. eCollection 2016 Mar.

13.

Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

Awadzi K, Opoku NO, Attah SK, Lazdins-Helds JK, Kuesel AC.

Parasit Vectors. 2015 Oct 9;8:515. doi: 10.1186/s13071-015-1122-9.

14.

The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.

Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, Basáñez MG.

Parasit Vectors. 2015 Mar 19;8:167. doi: 10.1186/s13071-015-0779-4.

15.

From bright ideas to tools: the case of malaria.

Gomes MF, Kuesel AC.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3377. doi: 10.1371/journal.pntd.0003377. eCollection 2015 Jan. No abstract available.

16.

A changing model for developing health products for poverty-related infectious diseases.

Olliaro PL, Kuesel AC, Reeder JC.

PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3379. doi: 10.1371/journal.pntd.0003379. eCollection 2015 Jan. No abstract available.

17.

A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.

Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC.

PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2953. doi: 10.1371/journal.pntd.0002953. eCollection 2014 Jun.

18.

Nodding syndrome.

Dowell SF, Sejvar JJ, Riek L, Vandemaele KA, Lamunu M, Kuesel AC, Schmutzhard E, Matuja W, Bunga S, Foltz J, Nutman TB, Winkler AS, Mbonye AK.

Emerg Infect Dis. 2013;19(9):1374-84. doi: 10.3201/eid1909.130401.

19.

Limited electricity access in health facilities of sub-Saharan Africa: a systematic review of data on electricity access, sources, and reliability.

Adair-Rohani H, Zukor K, Bonjour S, Wilburn S, Kuesel AC, Hebert R, Fletcher ER.

Glob Health Sci Pract. 2013 Aug 14;1(2):249-61. doi: 10.9745/GHSP-D-13-00037. eCollection 2013 Aug.

20.

Metabolic characterization of human soft tissue sarcomas in vivo and in vitro using proton-decoupled phosphorus magnetic resonance spectroscopy.

Li CW, Kuesel AC, Padavic-Shaller KA, Murphy-Boesch J, Eisenberg BL, Schmidt RG, von Roemeling RW, Patchefsky AS, Brown TR, Negendank WG.

Cancer Res. 1996 Jul 1;56(13):2964-72.

21.

Quantitation of resonances in biological 31P NMR spectra via principal component analysis: potential and limitations.

Kuesel AC, Stoyanova R, Aiken NR, Li CW, Szwergold BS, Shaller C, Brown TR.

NMR Biomed. 1996 May;9(3):93-104.

PMID:
8892395
22.

Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy.

Somorjai RL, Dolenko B, Nikulin AK, Pizzi N, Scarth G, Zhilkin P, Halliday W, Fewer D, Hill N, Ross I, West M, Smith IC, Donnelly SM, Kuesel AC, Brière KM.

J Magn Reson Imaging. 1996 May-Jun;6(3):437-44.

PMID:
8724408
23.

Mobile lipid accumulation in necrotic tissue of high grade astrocytomas.

Kuesel AC, Briere KM, Halliday WC, Sutherland GR, Donnelly SM, Smith IC.

Anticancer Res. 1996 May-Jun;16(3B):1485-9.

PMID:
8694517
24.

31P MRS of human tumor cells: effects of culture media and conditions on phospholipid metabolite concentrations.

Franks SE, Kuesel AC, Lutz NW, Hull WE.

Anticancer Res. 1996 May-Jun;16(3B):1365-74.

PMID:
8694503
25.

Metabolism of phosphonium choline by rat-2 fibroblasts: effects of mitogenic stimulation studied using 31P NMR spectroscopy.

Aiken NR, Szwergold ES, Kappler F, Stoyanova R, Kuesel AC, Shaller C, Brown TR.

Anticancer Res. 1996 May-Jun;16(3B):1357-63.

PMID:
8694502
26.

1H MR visible lipids in colon tissue from normal and carcinogen-treated rats.

Brière KM, Kuesel AC, Bird RP, Smith IC.

NMR Biomed. 1995 Feb;8(1):33-40.

PMID:
7547183
27.

Mobile lipids and metabolic heterogeneity of brain tumours as detectable by ex vivo 1H MR spectroscopy.

Kuesel AC, Donnelly SM, Halliday W, Sutherland GR, Smith IC.

NMR Biomed. 1994 Jun;7(4):172-80.

PMID:
7946995
28.

1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue.

Kuesel AC, Sutherland GR, Halliday W, Smith IC.

NMR Biomed. 1994 May;7(3):149-55.

PMID:
8080717
29.

A 1H-NMR method for determining temperature in cell culture perfusion systems.

Lutz NW, Kuesel AC, Hull WE.

Magn Reson Med. 1993 Jan;29(1):113-8.

PMID:
8419730
30.

A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies.

Kuesel AC, Kroft T, Saunders JK, Préfontaine M, Mikhael N, Smith IC.

Magn Reson Med. 1992 Oct;27(2):349-55.

PMID:
1461119
31.

Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease.

Kuesel AC, Kroft T, Préfontaine M, Smith IC.

Int J Cancer. 1992 Sep 30;52(3):341-6.

PMID:
1399109
32.

Supplemental Content

Loading ...
Support Center